
Abbott Laboratories agreed to pay $384M to settle allegations it sold contaminated infant formula to federal programs, the United States Justice Department said on Monday evening.
Abbott Laboratories agreed to pay over 384 million dollars to resolve claims it manufactured infant formula in risky conditions. The settlement closes a federal probe following a 2022 product recall.

Abbott Laboratories agreed to pay $384M to settle allegations it sold contaminated infant formula to federal programs, the United States Justice Department said on Monday evening.
Everything you use on the web — faster, and in your pocket.